Intravitreal injections (Avastin, Lucentis)

completely changed following the introduction of avastin.
Avastin and lucentis are drugs used for treating exudative maculopathy with great success. These medications can stop the disease’s development and, in some cases, even improve vision, They are injected inside the eye so that they can stop neovessels growth: this is typical of exudative maculopathy.

Injection is performed as an outpatient treatment in a few minutes; anyway, this process is performed in the operatory room in order to guarantee sterility.
More than one injections is needed in a timespan of 1 to 3 months, until vision quality settles.

The current therapeutic orientation consists in perform a cycle of 3 injections (loading phase) and then intervene again only in case of loss of vision or new liquid presence when performing OCT and angiography exams.

Maculopathy therapy with Avastin and Lucentis should be followed with extreme caution by heart patients. There is also a risk linked to intravitreal injection that is infection (endophthalmitis, about 1.5%).

Giovanna Cataudella, Catania

Votazione: Eccellente
Before surgery my daily activities were very penalized because my visual acuity was very reduced; I had lost most of my independence and this had even caused a nasty fall with a broken wrist.

The surgery had an excell... Keep on reading this reviewent outcome and I didn’t feel any discomfort during or after it.

The view has immediately improved, so that I could afford to go to lunch at the restaurant immediately after.